Latest total assets for NKGN: $16M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
NKGen Biotech (NKGN) currently reports a total assets of $16M as of March 2025. That compares with $27M in the prior-year period — down 40.7% year over year. Use the charts on this page to explore NKGen Biotech's total assets history and peer comparisons.
NKGen Biotech's total assets decreased from $27M to $16M — a 40.7% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
NKGen Biotech reported $16M in total assets as of March 2025. That compares with $27M in the prior-year period — down 40.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NKGen Biotech, and consider following NKGN for alerts when major investors trade the stock.